| pubmed-article:11125278 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11125278 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:11125278 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:11125278 | lifeskim:mentions | umls-concept:C0005773 | lld:lifeskim |
| pubmed-article:11125278 | lifeskim:mentions | umls-concept:C0370231 | lld:lifeskim |
| pubmed-article:11125278 | lifeskim:mentions | umls-concept:C0007585 | lld:lifeskim |
| pubmed-article:11125278 | lifeskim:mentions | umls-concept:C0021745 | lld:lifeskim |
| pubmed-article:11125278 | lifeskim:mentions | umls-concept:C2754073 | lld:lifeskim |
| pubmed-article:11125278 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11125278 | pubmed:dateCreated | 2001-1-22 | lld:pubmed |
| pubmed-article:11125278 | pubmed:abstractText | Secretion of interleukin-2 (IL-2) and interferon-gamma (IFNgamma) in whole blood cell cultures after phytohemagglutinin (PHA) and pokeweed mitogen (PWM) stimulation was evaluated in 42 small-cell lung cancer patients before treatment. Blood cultures from patients with extensive and limited disease have lower IFNgamma secretions after PWM stimulation and lower IL-2 secretions after PWM and PHA stimulation, but this was not statistically significant. IFNgamma but not IL-2 secretion was significantly higher after PWM stimulation in cultures from patients with better clinical performance status (0 + 1, WHO scale). Blood cultures from patients with tumor regression after treatment had a higher secretion of IFNgamma after PWM stimulation. In contrast, blood cultures from patients with a poor prognosis had significantly lower IL-2 and IFNgamma secretions after stimulation with PWM, and a lower IL-2 secretion after stimulation with PHA. | lld:pubmed |
| pubmed-article:11125278 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11125278 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11125278 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11125278 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11125278 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11125278 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11125278 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11125278 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11125278 | pubmed:issn | 1010-4283 | lld:pubmed |
| pubmed-article:11125278 | pubmed:author | pubmed-author:RogalaEE | lld:pubmed |
| pubmed-article:11125278 | pubmed:author | pubmed-author:von KleistSS | lld:pubmed |
| pubmed-article:11125278 | pubmed:author | pubmed-author:Rowi?ska-Zakr... | lld:pubmed |
| pubmed-article:11125278 | pubmed:author | pubmed-author:Szopi?skiJJ | lld:pubmed |
| pubmed-article:11125278 | pubmed:author | pubmed-author:Rogi?skaEE | lld:pubmed |
| pubmed-article:11125278 | pubmed:author | pubmed-author:PanorskaAA | lld:pubmed |
| pubmed-article:11125278 | pubmed:copyrightInfo | Copyright 2001 S. Karger AG, Basel | lld:pubmed |
| pubmed-article:11125278 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11125278 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:11125278 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11125278 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11125278 | pubmed:pagination | 72-6 | lld:pubmed |
| pubmed-article:11125278 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:meshHeading | pubmed-meshheading:11125278... | lld:pubmed |
| pubmed-article:11125278 | pubmed:articleTitle | Interferon gamma and interleukin-2 secretion in whole blood cell cultures from small-cell lung cancer patients. | lld:pubmed |
| pubmed-article:11125278 | pubmed:affiliation | National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland. j.szopinski@igichp.edu | lld:pubmed |
| pubmed-article:11125278 | pubmed:publicationType | Journal Article | lld:pubmed |
